Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 82 | 2024 | 5706 | 7.040 |
Why?
|
Skin Neoplasms | 31 | 2024 | 5863 | 2.240 |
Why?
|
Immunotherapy | 32 | 2024 | 4754 | 1.780 |
Why?
|
Oncolytic Virotherapy | 6 | 2024 | 520 | 1.610 |
Why?
|
Proto-Oncogene Proteins B-raf | 15 | 2023 | 2059 | 0.990 |
Why?
|
Drug Resistance, Neoplasm | 20 | 2024 | 5341 | 0.980 |
Why?
|
Neoplasms, Second Primary | 2 | 2023 | 1061 | 0.890 |
Why?
|
Oncolytic Viruses | 3 | 2023 | 344 | 0.860 |
Why?
|
Receptors, Nerve Growth Factor | 2 | 2021 | 199 | 0.850 |
Why?
|
Tumor Microenvironment | 17 | 2024 | 3948 | 0.710 |
Why?
|
Neoplasms | 18 | 2024 | 22371 | 0.680 |
Why?
|
Protein Kinase Inhibitors | 14 | 2024 | 5704 | 0.610 |
Why?
|
Sarcopenia | 1 | 2023 | 378 | 0.610 |
Why?
|
Sentinel Lymph Node Biopsy | 6 | 2021 | 737 | 0.560 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2024 | 1756 | 0.530 |
Why?
|
Xenograft Model Antitumor Assays | 11 | 2024 | 3612 | 0.520 |
Why?
|
CD8-Positive T-Lymphocytes | 11 | 2024 | 4648 | 0.520 |
Why?
|
Uveal Neoplasms | 3 | 2024 | 344 | 0.500 |
Why?
|
General Surgery | 2 | 2024 | 1720 | 0.490 |
Why?
|
MAP Kinase Signaling System | 5 | 2018 | 1495 | 0.460 |
Why?
|
Immunologic Factors | 2 | 2022 | 1596 | 0.460 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2023 | 3670 | 0.450 |
Why?
|
Humans | 133 | 2025 | 768171 | 0.430 |
Why?
|
Neoadjuvant Therapy | 2 | 2024 | 2907 | 0.430 |
Why?
|
Lymph Node Excision | 3 | 2021 | 1271 | 0.420 |
Why?
|
Lymphatic Metastasis | 3 | 2017 | 2914 | 0.420 |
Why?
|
Women, Working | 1 | 2013 | 86 | 0.390 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2420 | 0.390 |
Why?
|
Neoplasm, Residual | 3 | 2024 | 1015 | 0.390 |
Why?
|
Combined Modality Therapy | 7 | 2024 | 8542 | 0.390 |
Why?
|
Neoplasm Staging | 13 | 2024 | 11244 | 0.390 |
Why?
|
Glucocorticoids | 1 | 2021 | 2167 | 0.390 |
Why?
|
Pancreatic Neoplasms | 3 | 2024 | 5442 | 0.380 |
Why?
|
Single-Cell Analysis | 9 | 2024 | 2540 | 0.380 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 4413 | 0.370 |
Why?
|
Molecular Targeted Therapy | 4 | 2024 | 2830 | 0.360 |
Why?
|
Cell Line, Tumor | 27 | 2024 | 17142 | 0.360 |
Why?
|
Prognosis | 16 | 2024 | 30009 | 0.350 |
Why?
|
Patient Participation | 1 | 2019 | 1447 | 0.340 |
Why?
|
MAP Kinase Kinase 1 | 3 | 2021 | 331 | 0.340 |
Why?
|
Object Attachment | 1 | 2013 | 326 | 0.330 |
Why?
|
Tumor Burden | 4 | 2024 | 1906 | 0.330 |
Why?
|
Parent-Child Relations | 1 | 2013 | 772 | 0.290 |
Why?
|
Physician's Role | 1 | 2014 | 925 | 0.280 |
Why?
|
Mutation | 16 | 2024 | 30237 | 0.280 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2021 | 8648 | 0.270 |
Why?
|
Physicians, Women | 1 | 2013 | 517 | 0.270 |
Why?
|
Telomerase | 2 | 2024 | 751 | 0.270 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2023 | 9419 | 0.260 |
Why?
|
Granzymes | 2 | 2018 | 277 | 0.260 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3269 | 0.260 |
Why?
|
Adjuvants, Immunologic | 2 | 2022 | 999 | 0.250 |
Why?
|
Antigens, Neoplasm | 3 | 2022 | 1996 | 0.250 |
Why?
|
Colonic Neoplasms | 2 | 2018 | 2541 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2018 | 354 | 0.240 |
Why?
|
Tissue Adhesions | 1 | 2006 | 223 | 0.240 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2024 | 34 | 0.230 |
Why?
|
Melanoma, Experimental | 2 | 2020 | 559 | 0.230 |
Why?
|
Internship and Residency | 2 | 2024 | 5953 | 0.230 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2018 | 565 | 0.230 |
Why?
|
DNA, Mitochondrial | 2 | 2020 | 872 | 0.230 |
Why?
|
Ploidies | 1 | 2024 | 287 | 0.230 |
Why?
|
Caspase 9 | 1 | 2024 | 184 | 0.230 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1512 | 0.230 |
Why?
|
Antigen Presentation | 2 | 2021 | 1251 | 0.230 |
Why?
|
Colitis | 2 | 2024 | 1242 | 0.220 |
Why?
|
Neoplasm Metastasis | 7 | 2024 | 4913 | 0.220 |
Why?
|
Neural Stem Cells | 2 | 2021 | 895 | 0.200 |
Why?
|
GPI-Linked Proteins | 1 | 2024 | 472 | 0.200 |
Why?
|
Fucose | 1 | 2023 | 122 | 0.200 |
Why?
|
Guideline Adherence | 1 | 2012 | 2235 | 0.200 |
Why?
|
Immune Evasion | 2 | 2023 | 375 | 0.200 |
Why?
|
Mice | 31 | 2024 | 82049 | 0.200 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2023 | 1105 | 0.200 |
Why?
|
Blood | 1 | 2024 | 599 | 0.200 |
Why?
|
Survival Rate | 6 | 2024 | 12840 | 0.190 |
Why?
|
Receptors, CXCR3 | 2 | 2020 | 240 | 0.190 |
Why?
|
Osteogenesis | 2 | 2007 | 1295 | 0.190 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2021 | 78 | 0.190 |
Why?
|
Leiomyosarcoma | 2 | 2016 | 426 | 0.190 |
Why?
|
Female | 45 | 2024 | 397187 | 0.180 |
Why?
|
Collagen Type I | 1 | 2024 | 620 | 0.180 |
Why?
|
Nissl Bodies | 1 | 2020 | 16 | 0.180 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 58 | 0.180 |
Why?
|
Medical Oncology | 3 | 2024 | 2346 | 0.180 |
Why?
|
Microsatellite Instability | 1 | 2024 | 726 | 0.180 |
Why?
|
Male | 39 | 2024 | 364731 | 0.180 |
Why?
|
Endopeptidases | 1 | 2024 | 764 | 0.170 |
Why?
|
Nephritis | 1 | 2021 | 147 | 0.170 |
Why?
|
Weightlessness | 1 | 2021 | 103 | 0.170 |
Why?
|
Saliva | 1 | 2025 | 853 | 0.170 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 361 | 0.170 |
Why?
|
Abdomen | 1 | 2006 | 1136 | 0.170 |
Why?
|
Colorectal Neoplasms | 5 | 2024 | 6975 | 0.170 |
Why?
|
Antigens, Differentiation | 1 | 2022 | 921 | 0.170 |
Why?
|
Transferrin | 1 | 2020 | 283 | 0.170 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2024 | 1801 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2020 | 110 | 0.160 |
Why?
|
Cryosurgery | 1 | 2024 | 479 | 0.160 |
Why?
|
Tumor Escape | 2 | 2020 | 372 | 0.160 |
Why?
|
Cysteine | 1 | 2024 | 897 | 0.160 |
Why?
|
Neural Crest | 1 | 2021 | 278 | 0.160 |
Why?
|
Proteins | 4 | 2018 | 6009 | 0.160 |
Why?
|
Cancer Vaccines | 2 | 2024 | 1040 | 0.160 |
Why?
|
Herpesvirus 1, Human | 1 | 2024 | 743 | 0.160 |
Why?
|
Retrospective Studies | 13 | 2024 | 81760 | 0.160 |
Why?
|
Aged, 80 and over | 14 | 2024 | 59626 | 0.160 |
Why?
|
Retinoid X Receptor gamma | 1 | 2018 | 2 | 0.160 |
Why?
|
Lipogenesis | 1 | 2020 | 217 | 0.160 |
Why?
|
Animals | 35 | 2024 | 169285 | 0.160 |
Why?
|
Parents | 1 | 2013 | 3595 | 0.160 |
Why?
|
Myeloid Cells | 2 | 2021 | 839 | 0.160 |
Why?
|
Benzimidazoles | 2 | 2021 | 864 | 0.160 |
Why?
|
Poisson Distribution | 1 | 2020 | 506 | 0.160 |
Why?
|
Disease Progression | 5 | 2024 | 13668 | 0.160 |
Why?
|
Adaptation, Biological | 1 | 2019 | 147 | 0.150 |
Why?
|
Adenoviridae | 1 | 2023 | 1093 | 0.150 |
Why?
|
Thionucleosides | 1 | 2018 | 13 | 0.150 |
Why?
|
Genes, cdc | 1 | 2018 | 113 | 0.150 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2022 | 1361 | 0.150 |
Why?
|
T-Lymphocytes | 6 | 2024 | 10266 | 0.150 |
Why?
|
Tumor Cells, Cultured | 6 | 2022 | 6124 | 0.150 |
Why?
|
Program Development | 1 | 2024 | 1300 | 0.150 |
Why?
|
Exanthema | 1 | 2023 | 503 | 0.150 |
Why?
|
PPAR gamma | 1 | 2021 | 487 | 0.150 |
Why?
|
Space Flight | 1 | 2021 | 219 | 0.150 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2012 | 329 | 0.150 |
Why?
|
DNA Copy Number Variations | 2 | 2024 | 2048 | 0.150 |
Why?
|
Deoxyguanosine | 1 | 2018 | 96 | 0.150 |
Why?
|
Aged | 22 | 2024 | 171502 | 0.150 |
Why?
|
Mesenchymal Stem Cells | 2 | 2007 | 1673 | 0.150 |
Why?
|
Interleukin-2 | 2 | 2022 | 1895 | 0.140 |
Why?
|
Exosomes | 1 | 2022 | 423 | 0.140 |
Why?
|
Melanoma, Amelanotic | 1 | 2017 | 19 | 0.140 |
Why?
|
Oxidation-Reduction | 2 | 2024 | 2227 | 0.140 |
Why?
|
Enteric Nervous System | 1 | 2020 | 213 | 0.140 |
Why?
|
Substrate Specificity | 1 | 2021 | 1751 | 0.140 |
Why?
|
Receptors, Chemokine | 1 | 2020 | 652 | 0.140 |
Why?
|
Single-Blind Method | 1 | 2021 | 1587 | 0.140 |
Why?
|
Myocarditis | 1 | 2024 | 802 | 0.140 |
Why?
|
Indoles | 3 | 2020 | 1836 | 0.140 |
Why?
|
p21-Activated Kinases | 1 | 2017 | 127 | 0.140 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2017 | 67 | 0.140 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2022 | 724 | 0.140 |
Why?
|
Colonic Polyps | 1 | 2021 | 557 | 0.140 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1418 | 0.130 |
Why?
|
Prednisone | 1 | 2021 | 1567 | 0.130 |
Why?
|
Mitochondria | 2 | 2020 | 3683 | 0.130 |
Why?
|
Middle Aged | 23 | 2024 | 223487 | 0.130 |
Why?
|
Computer Communication Networks | 1 | 1998 | 295 | 0.130 |
Why?
|
Cell Differentiation | 6 | 2021 | 11677 | 0.130 |
Why?
|
Polyethylene Glycols | 1 | 2022 | 1197 | 0.130 |
Why?
|
Positron-Emission Tomography | 3 | 2024 | 6669 | 0.130 |
Why?
|
Cell Proliferation | 5 | 2021 | 10478 | 0.130 |
Why?
|
Program Evaluation | 1 | 2024 | 2507 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2024 | 3556 | 0.130 |
Why?
|
Antibodies, Monoclonal | 4 | 2021 | 9262 | 0.130 |
Why?
|
Sulfonamides | 3 | 2020 | 1982 | 0.120 |
Why?
|
Immunomodulation | 1 | 2019 | 549 | 0.120 |
Why?
|
Biological Products | 1 | 2024 | 947 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2023 | 4415 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6525 | 0.120 |
Why?
|
Signal Transduction | 9 | 2024 | 23648 | 0.120 |
Why?
|
Drug Synergism | 1 | 2019 | 1760 | 0.120 |
Why?
|
DNA, Neoplasm | 1 | 2020 | 1744 | 0.120 |
Why?
|
Wnt Proteins | 4 | 2007 | 725 | 0.120 |
Why?
|
Vascular Neoplasms | 1 | 2016 | 167 | 0.120 |
Why?
|
Remission Induction | 1 | 2020 | 2410 | 0.110 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1351 | 0.110 |
Why?
|
Mentors | 1 | 2019 | 671 | 0.110 |
Why?
|
Mice, SCID | 4 | 2021 | 2627 | 0.110 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2785 | 0.110 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2020 | 952 | 0.110 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 1232 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2024 | 65379 | 0.110 |
Why?
|
Regression Analysis | 1 | 2023 | 6340 | 0.110 |
Why?
|
Chemokines | 3 | 2024 | 963 | 0.110 |
Why?
|
Interprofessional Relations | 1 | 2019 | 997 | 0.110 |
Why?
|
Phylogeny | 1 | 2021 | 2843 | 0.110 |
Why?
|
Intestinal Mucosa | 1 | 2024 | 3044 | 0.100 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1657 | 0.100 |
Why?
|
Brain Neoplasms | 3 | 2023 | 9118 | 0.100 |
Why?
|
Pilot Projects | 2 | 2024 | 8741 | 0.100 |
Why?
|
Endoplasmic Reticulum | 1 | 2018 | 1133 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1246 | 0.100 |
Why?
|
Bone Morphogenetic Proteins | 3 | 2021 | 846 | 0.100 |
Why?
|
Gene Expression Profiling | 5 | 2024 | 9540 | 0.100 |
Why?
|
Cholecystitis | 1 | 1993 | 181 | 0.100 |
Why?
|
Blood Proteins | 1 | 2017 | 1191 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 998 | 0.100 |
Why?
|
Tissue and Organ Procurement | 1 | 2020 | 986 | 0.100 |
Why?
|
Cross Infection | 1 | 2021 | 1425 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1886 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2021 | 4939 | 0.100 |
Why?
|
Time Factors | 4 | 2021 | 40220 | 0.100 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12543 | 0.100 |
Why?
|
Myocardium | 1 | 2024 | 4790 | 0.090 |
Why?
|
Fatty Acids | 1 | 2019 | 1812 | 0.090 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2015 | 335 | 0.090 |
Why?
|
Adult | 18 | 2024 | 223646 | 0.090 |
Why?
|
Boston | 2 | 2021 | 9374 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2019 | 1226 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1837 | 0.090 |
Why?
|
Curriculum | 1 | 2024 | 3782 | 0.090 |
Why?
|
Muscle, Smooth | 1 | 2015 | 931 | 0.090 |
Why?
|
Chondrogenesis | 2 | 2002 | 239 | 0.090 |
Why?
|
Lymphocyte Activation | 2 | 2019 | 5505 | 0.090 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6316 | 0.090 |
Why?
|
Quality Control | 1 | 2012 | 836 | 0.080 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13586 | 0.080 |
Why?
|
Genetic Heterogeneity | 2 | 2024 | 736 | 0.080 |
Why?
|
Transforming Growth Factor beta | 3 | 2020 | 2004 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7454 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3610 | 0.080 |
Why?
|
Mesoderm | 2 | 2002 | 679 | 0.080 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13677 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1887 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2024 | 2568 | 0.080 |
Why?
|
Spheroids, Cellular | 2 | 2023 | 331 | 0.080 |
Why?
|
Membrane Glycoproteins | 1 | 2019 | 3713 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2666 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4363 | 0.080 |
Why?
|
Proteome | 1 | 2017 | 1890 | 0.070 |
Why?
|
Genomics | 3 | 2024 | 5926 | 0.070 |
Why?
|
Germ-Line Mutation | 1 | 2015 | 1885 | 0.070 |
Why?
|
Computational Biology | 1 | 2019 | 3567 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3604 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2257 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5797 | 0.070 |
Why?
|
Mice, Knockout | 5 | 2020 | 14488 | 0.070 |
Why?
|
Flow Cytometry | 3 | 2020 | 5902 | 0.070 |
Why?
|
Taste | 2 | 2004 | 190 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2020 | 637 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 22380 | 0.060 |
Why?
|
Uterine Neoplasms | 1 | 2015 | 1424 | 0.060 |
Why?
|
Genome, Human | 2 | 2020 | 4446 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7477 | 0.060 |
Why?
|
Cohort Studies | 5 | 2023 | 41753 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2020 | 12801 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15453 | 0.060 |
Why?
|
Stromal Cells | 2 | 2021 | 1337 | 0.060 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2025 | 820 | 0.060 |
Why?
|
Disease-Free Survival | 3 | 2022 | 6847 | 0.060 |
Why?
|
Oximes | 2 | 2017 | 303 | 0.060 |
Why?
|
Ventricular Myosins | 1 | 2024 | 65 | 0.060 |
Why?
|
Phosphorylation | 3 | 2022 | 8316 | 0.060 |
Why?
|
Intensive Care Units | 2 | 2021 | 3800 | 0.060 |
Why?
|
Cell Lineage | 3 | 2024 | 2575 | 0.060 |
Why?
|
Sequence Analysis, RNA | 2 | 2023 | 2040 | 0.060 |
Why?
|
Colon | 2 | 2024 | 1801 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2016 | 3474 | 0.060 |
Why?
|
Calcification, Physiologic | 1 | 2004 | 170 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2023 | 3161 | 0.060 |
Why?
|
SOXE Transcription Factors | 1 | 2024 | 73 | 0.060 |
Why?
|
Monosomy | 1 | 2024 | 52 | 0.060 |
Why?
|
Attitude to Health | 1 | 2013 | 2025 | 0.060 |
Why?
|
Gallium Radioisotopes | 1 | 2024 | 195 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2019 | 1864 | 0.050 |
Why?
|
Transfection | 2 | 2017 | 5756 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2020 | 19025 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2006 | 15833 | 0.050 |
Why?
|
Exploratory Behavior | 1 | 2004 | 272 | 0.050 |
Why?
|
Sucrose | 1 | 2003 | 157 | 0.050 |
Why?
|
Alcoholism | 2 | 2004 | 1980 | 0.050 |
Why?
|
Luciferases | 1 | 2004 | 713 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 109 | 0.050 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 1 | 2022 | 38 | 0.050 |
Why?
|
Succinates | 1 | 2022 | 83 | 0.050 |
Why?
|
RNA | 2 | 2023 | 2722 | 0.050 |
Why?
|
Leucovorin | 1 | 2024 | 643 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2007 | 4528 | 0.050 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 26 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 2885 | 0.050 |
Why?
|
Retroviridae | 1 | 2004 | 846 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 189 | 0.050 |
Why?
|
Sweetening Agents | 1 | 2004 | 290 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 253 | 0.050 |
Why?
|
Adenocarcinoma | 2 | 2024 | 6395 | 0.050 |
Why?
|
Registries | 1 | 2017 | 8375 | 0.050 |
Why?
|
Apoptosis | 3 | 2021 | 9527 | 0.050 |
Why?
|
Vancomycin | 1 | 2024 | 506 | 0.050 |
Why?
|
Neurons | 1 | 2020 | 9514 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3803 | 0.050 |
Why?
|
Endoplasmic Reticulum, Rough | 1 | 2020 | 21 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18349 | 0.040 |
Why?
|
Fathers | 1 | 2003 | 377 | 0.040 |
Why?
|
Cell Compartmentation | 1 | 2021 | 383 | 0.040 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2020 | 59 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18065 | 0.040 |
Why?
|
Telemedicine | 1 | 1998 | 3109 | 0.040 |
Why?
|
Autoantigens | 1 | 2024 | 890 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2020 | 4280 | 0.040 |
Why?
|
Imidazoles | 2 | 2017 | 1169 | 0.040 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2020 | 120 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2024 | 3703 | 0.040 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2025 | 445 | 0.040 |
Why?
|
Troponin I | 1 | 2024 | 662 | 0.040 |
Why?
|
Food Preferences | 1 | 2003 | 398 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2021 | 239 | 0.040 |
Why?
|
Censuses | 1 | 2021 | 198 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10099 | 0.040 |
Why?
|
Eye Enucleation | 1 | 2020 | 128 | 0.040 |
Why?
|
Risk Factors | 4 | 2021 | 74944 | 0.040 |
Why?
|
Stem Cells | 2 | 2023 | 3538 | 0.040 |
Why?
|
beta Catenin | 3 | 2017 | 1047 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2023 | 1989 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2006 | 1162 | 0.040 |
Why?
|
Caspases | 1 | 2023 | 882 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 892 | 0.040 |
Why?
|
Troponin T | 1 | 2024 | 787 | 0.040 |
Why?
|
Simplexvirus | 1 | 2023 | 805 | 0.040 |
Why?
|
Microfluidics | 1 | 2025 | 672 | 0.040 |
Why?
|
Microscopy | 1 | 2024 | 909 | 0.040 |
Why?
|
Fluorouracil | 1 | 2024 | 1652 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2004 | 1165 | 0.040 |
Why?
|
Risk Assessment | 1 | 2021 | 24318 | 0.040 |
Why?
|
Vimentin | 1 | 2020 | 257 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2017 | 3590 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2024 | 1027 | 0.040 |
Why?
|
Transposases | 1 | 2019 | 106 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3445 | 0.040 |
Why?
|
Lithium | 1 | 2002 | 600 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 60066 | 0.040 |
Why?
|
Trachea | 1 | 2004 | 1095 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 687 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 960 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2024 | 3115 | 0.040 |
Why?
|
Communication | 1 | 2013 | 3905 | 0.040 |
Why?
|
Incidence | 3 | 2023 | 21538 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1715 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2017 | 11095 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 72 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 431 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2020 | 168 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 720 | 0.040 |
Why?
|
PPAR alpha | 1 | 2019 | 177 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 53 | 0.040 |
Why?
|
Mice, Nude | 1 | 2024 | 3623 | 0.040 |
Why?
|
Feces | 1 | 2025 | 1511 | 0.040 |
Why?
|
Membrane Proteins | 3 | 2024 | 7876 | 0.040 |
Why?
|
Teleradiology | 1 | 1998 | 52 | 0.040 |
Why?
|
Ileum | 1 | 2020 | 558 | 0.040 |
Why?
|
Proteomics | 2 | 2024 | 3912 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2018 | 384 | 0.040 |
Why?
|
Telecommunications | 1 | 1998 | 79 | 0.040 |
Why?
|
Sulfones | 1 | 2020 | 448 | 0.040 |
Why?
|
Adaptor Protein Complex sigma Subunits | 1 | 2017 | 10 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2022 | 878 | 0.040 |
Why?
|
Melanocytes | 1 | 2021 | 509 | 0.040 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2018 | 252 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9561 | 0.040 |
Why?
|
Fibrosis | 1 | 2024 | 2081 | 0.030 |
Why?
|
Ribosomes | 1 | 2020 | 497 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 205 | 0.030 |
Why?
|
Ligands | 1 | 2024 | 3284 | 0.030 |
Why?
|
Multigene Family | 1 | 2020 | 1081 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2022 | 2230 | 0.030 |
Why?
|
Biopsy | 2 | 2020 | 6792 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36741 | 0.030 |
Why?
|
Efficiency | 1 | 2000 | 479 | 0.030 |
Why?
|
Acetanilides | 1 | 2018 | 169 | 0.030 |
Why?
|
Clone Cells | 1 | 2020 | 1670 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2017 | 330 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2021 | 733 | 0.030 |
Why?
|
Inflammation | 3 | 2021 | 10873 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
Arginine | 1 | 2020 | 932 | 0.030 |
Why?
|
HLA Antigens | 1 | 2022 | 1334 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1737 | 0.030 |
Why?
|
Organoids | 1 | 2023 | 743 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1854 | 0.030 |
Why?
|
Cell Cycle | 1 | 2004 | 2934 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 2021 | 1148 | 0.030 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2020 | 605 | 0.030 |
Why?
|
Biomarkers, Pharmacological | 1 | 2017 | 162 | 0.030 |
Why?
|
Cell Death | 1 | 2021 | 1680 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2014 | 5367 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3833 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1606 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2000 | 771 | 0.030 |
Why?
|
United States | 4 | 2024 | 73039 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 21207 | 0.030 |
Why?
|
Apyrase | 1 | 2018 | 376 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 505 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 440 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2000 | 533 | 0.030 |
Why?
|
Gene Dosage | 1 | 2020 | 1219 | 0.030 |
Why?
|
Cryopreservation | 1 | 2021 | 733 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2494 | 0.030 |
Why?
|
Trans-Activators | 2 | 2002 | 2857 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
Viral Load | 1 | 2025 | 3396 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2002 | 1019 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2018 | 296 | 0.030 |
Why?
|
Cofilin 2 | 1 | 2015 | 12 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2020 | 1791 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 663 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1767 | 0.030 |
Why?
|
Glycolysis | 1 | 2019 | 837 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2017 | 386 | 0.030 |
Why?
|
Desmin | 1 | 2015 | 99 | 0.030 |
Why?
|
Germ Cells | 1 | 2019 | 644 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2018 | 797 | 0.030 |
Why?
|
Base Sequence | 2 | 2019 | 12422 | 0.030 |
Why?
|
Wound Healing | 1 | 2006 | 2815 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 960 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 829 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2735 | 0.030 |
Why?
|
Bone Marrow | 1 | 2004 | 2935 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 710 | 0.030 |
Why?
|
Epitopes | 1 | 2021 | 2527 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2004 | 2909 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2002 | 1599 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4178 | 0.030 |
Why?
|
Interleukins | 1 | 2019 | 796 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2004 | 2649 | 0.030 |
Why?
|
Cytokines | 2 | 2020 | 7452 | 0.030 |
Why?
|
Genome | 1 | 2022 | 1754 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1793 | 0.030 |
Why?
|
Confidentiality | 1 | 1998 | 607 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16726 | 0.030 |
Why?
|
Precipitating Factors | 1 | 1993 | 51 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2024 | 2747 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1752 | 0.030 |
Why?
|
Cholangiography | 1 | 1993 | 182 | 0.030 |
Why?
|
Protein Transport | 1 | 2018 | 1951 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2024 | 39354 | 0.030 |
Why?
|
Doxycycline | 1 | 2015 | 349 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11930 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 874 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2002 | 1893 | 0.030 |
Why?
|
Glycogen Synthase Kinases | 2 | 2002 | 40 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1230 | 0.030 |
Why?
|
Point Mutation | 1 | 2017 | 1596 | 0.020 |
Why?
|
Brachytherapy | 1 | 2020 | 1220 | 0.020 |
Why?
|
Pyridones | 1 | 2017 | 819 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2024 | 16044 | 0.020 |
Why?
|
Quinolines | 1 | 2017 | 772 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7609 | 0.020 |
Why?
|
Genes, p53 | 1 | 2014 | 714 | 0.020 |
Why?
|
Monocytes | 1 | 2021 | 2605 | 0.020 |
Why?
|
Telomere | 1 | 2018 | 943 | 0.020 |
Why?
|
International Cooperation | 1 | 1998 | 1436 | 0.020 |
Why?
|
Genotype | 2 | 2019 | 13045 | 0.020 |
Why?
|
Transgenes | 1 | 2015 | 1016 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2018 | 1273 | 0.020 |
Why?
|
Heart | 1 | 2024 | 4446 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4793 | 0.020 |
Why?
|
Antibodies | 1 | 2019 | 2421 | 0.020 |
Why?
|
Europe | 1 | 1998 | 3436 | 0.020 |
Why?
|
Models, Biological | 3 | 2019 | 9497 | 0.020 |
Why?
|
Adenoma | 1 | 2021 | 2159 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 525 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2059 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1816 | 0.020 |
Why?
|
Cholecystectomy | 1 | 1993 | 408 | 0.020 |
Why?
|
Autophagy | 1 | 2018 | 1351 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2002 | 492 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2981 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2014 | 725 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4206 | 0.020 |
Why?
|
Estradiol | 1 | 2017 | 1951 | 0.020 |
Why?
|
Tamoxifen | 1 | 2015 | 966 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1628 | 0.020 |
Why?
|
Bone Morphogenetic Protein 2 | 2 | 2002 | 344 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2002 | 414 | 0.020 |
Why?
|
Neuroblastoma | 1 | 2018 | 1266 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1667 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1662 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6231 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2566 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1536 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4786 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1896 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1120 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3786 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3589 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2062 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6894 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4035 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5213 | 0.020 |
Why?
|
Chi-Square Distribution | 2 | 2004 | 3436 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 905 | 0.020 |
Why?
|
Drainage | 1 | 1993 | 1183 | 0.020 |
Why?
|
Cadherins | 2 | 2002 | 905 | 0.020 |
Why?
|
Frizzled Receptors | 1 | 2007 | 90 | 0.020 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2007 | 118 | 0.020 |
Why?
|
Chromatin | 1 | 2019 | 2981 | 0.020 |
Why?
|
Osteocalcin | 1 | 2007 | 277 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22290 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2007 | 174 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3409 | 0.020 |
Why?
|
Cytoskeletal Proteins | 2 | 2002 | 1327 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3231 | 0.020 |
Why?
|
Skin | 1 | 2020 | 4505 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2007 | 521 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 1993 | 1131 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 1998 | 3390 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10397 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8052 | 0.010 |
Why?
|
Clinical Competence | 1 | 2019 | 4858 | 0.010 |
Why?
|
Mental Disorders | 1 | 2003 | 6873 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20225 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 11878 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2007 | 1524 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5804 | 0.010 |
Why?
|
Transcription Factors | 2 | 2018 | 12171 | 0.010 |
Why?
|
Acute Disease | 1 | 1993 | 7243 | 0.010 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2002 | 85 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8743 | 0.010 |
Why?
|
Smad4 Protein | 1 | 2002 | 193 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10840 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8747 | 0.010 |
Why?
|
Time and Motion Studies | 1 | 2000 | 143 | 0.010 |
Why?
|
Bone Regeneration | 1 | 2002 | 446 | 0.010 |
Why?
|
Data Display | 1 | 2000 | 174 | 0.010 |
Why?
|
Cartilage | 1 | 2002 | 811 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1993 | 14729 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1993 | 13013 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2000 | 541 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2002 | 1676 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54924 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27362 | 0.010 |
Why?
|
Pelvis | 1 | 2000 | 736 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2000 | 20762 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2002 | 2094 | 0.010 |
Why?
|
Medical Records Systems, Computerized | 1 | 2000 | 1196 | 0.010 |
Why?
|
Regeneration | 1 | 2002 | 1524 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10763 | 0.010 |
Why?
|
Child | 1 | 2017 | 80917 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 89169 | 0.010 |
Why?
|
Logistic Models | 1 | 2003 | 13290 | 0.000 |
Why?
|
Cell Line | 1 | 2002 | 15602 | 0.000 |
Why?
|
Substance-Related Disorders | 1 | 2003 | 4423 | 0.000 |
Why?
|
Radiology | 1 | 2000 | 2104 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9617 | 0.000 |
Why?
|